Insulin Cost Caps Draw Congress Support as Companies Pare Prices

The cost of insulin remains top-of-mind for senators, even as the largest manufacturers of the drug promise to lower what they charge for their most popular products.

Sens. Raphael Warnock (D-Ga.) and John Kennedy (R-La.) plan to introduce a bill to cap at $35 per month what people with private insurance and those without insurance pay for insulin, the lawmakers announced Thursday.

“This is transformational for the folks I’ve been talking to,” Warnock told reporters.

The bipartisan effort is the latest in a string of bills aimed at reducing insulin costs, a popular stance among consumers. Millions of Americans are ...